China NMPA Inspection - Mianyang Tianyi Biotechnology Co., Ltd. - December 21, 2020

The Sichuan Provincial Drug Administration published an announcement on December 21, 2020, concerning unannounced inspections conducted in 2020 for cosmetics manufacturing enterprises. This regulatory oversight, part of the broader National Medical Products Administration (NMPA) framework, targeted compliance within the cosmetics sector. The announcement references three distinct unannounced inspection reports, confirming that Mianyang Tianyi Biotechnology Co., Ltd., Tongjiang County Yudeyuan Run'er Biotechnology Co., Ltd., and Sichuan Jiajun Biotechnology Co., Ltd. were subject to these regulatory reviews during 2020. However, the provided content is limited to the announcement itself and the titles of the individual inspection notifications for each company. The detailed findings from these inspections, including specific violations, identified issues, or any mandatory corrective actions and their associated timelines, are not contained within this document. Consequently, a comprehensive summary of the main regulatory issues or required actions for these companies cannot be extracted from the provided text.